Price (delayed)
$28.11
Market cap
$16.68B
P/E Ratio
18.62
Dividend/share
$0.83
EPS
$1.51
Enterprise value
$22.52B
Founded in 1996, Royalty Pharma is the largest buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals
Special dividends are included in TTM DPS and yield
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.